MDA with DHAp and SLD Primaquine

DRUG2 trials

Sponsors

Ulrika Morris, Institut de Recherche pour le Developpement

Conditions

MalariaMalaria, Asymptomatic ParasitaemiaMalaria, FalciparumPlasmodium Infections

Unknown Phase

Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar

CompletedNCT02721186

Ulrika MorrisMalaria, Plasmodium Infections

Start: 2016-04-30End: 2017-09-30Updated: 2017-10-05

MDA and Targeted Control Against Plasmodium Carriage in the Sahel

Active, not recruitingNCT07281443

Institut de Recherche pour le DeveloppementMalaria, Asymptomatic Parasitaemia, Malaria, Falciparum

Start: 2024-09-23End: 2027-12-31Target: 18000Updated: 2025-12-15

Related Papers

A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting—high coverage and safety, but no significant impact on transmission

BMC Medicine2018-11-2053 citations